115 results
Page 5 of 6
6-K
EX-99.2
8gr7tl6r2z28vjp0xcn
10 Dec 19
ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix
12:00am
6-K
jt3gok12 iaam7zlsgf
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
6-K
EX-99.2
9jt2 blhp9aq9j
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
6-K
EX-99.2
m60wknsgb9p
7 Nov 19
Current report (foreign)
9:11am
6-K
EX-99.3
nx5wugt3htxpw 2mu
7 Nov 19
Current report (foreign)
9:11am
6-K
EX-99.1
bpomkl4w7
31 Oct 19
ObsEva Announces Clearance to Initiate Pivotal US Phase 3 Clinical
4:21pm
6-K
EX-99.1
6cpp2jyp8i
6 Sep 19
ObsEva Reports New Clinical Evidence of Nolasiban Mechanism of
8:27am
424B5
fjgusmzy0new
7 Aug 19
Prospectus supplement for primary offering
8:18am
6-K
EX-99.1
f6fbgb1i
7 Aug 19
Current report (foreign)
7:21am
6-K
EX-99.3
h946tg6u
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.2
7xyfr1hxgp i8jk9t
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
tyy4jm0 uw6bn
19 Jun 19
Current report (foreign)
4:30pm
6-K
EX-99.2
6554fp91e pihxuomu
9 May 19
Index to Unaudited Condensed Consolidated Financial Statements
6:05am
6-K
EX-99.3
7111n7ofauq2x
9 May 19
Index to Unaudited Condensed Consolidated Financial Statements
6:05am
6-K
EX-99.3
14tg73xci5 bzt
8 Nov 18
Index to Unaudited Condensed Consolidated Financial Statements
9:28am
6-K
EX-99.2
s3whmj8xv
8 Nov 18
Index to Unaudited Condensed Consolidated Financial Statements
9:28am
6-K
1szh6v6xays9nn63a
9 Oct 18
Current report (foreign)
4:42pm
6-K
48y0ybsvrfber rx519
3 Oct 18
Current report (foreign)
9:07am
6-K
sbgm lbluxbkw37aogq
28 Sep 18
Current report (foreign)
8:40am